C
Amneal Pharmaceuticals, Inc. AMRX
$10.48 $0.121.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025
Revenue 4.18% -4.80%
Total Other Revenue -- --
Total Revenue 4.18% -4.80%
Cost of Revenue -0.23% -5.82%
Gross Profit 11.85% -2.98%
SG&A Expenses 5.05% -8.08%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 3.03% -8.75%
Operating Income 10.99% 27.76%
Income Before Tax 37.95% 344.70%
Income Tax Expenses 25.12% 137.29%
Earnings from Continuing Operations 44.65% 218.69%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -6.20% -20.16%
Net Income 83.82% 139.24%
EBIT 10.99% 27.76%
EBITDA 6.86% 11.00%
EPS Basic 82.40% 139.08%
Normalized Basic EPS 70.41% 150.00%
EPS Diluted 78.57% 139.08%
Normalized Diluted EPS 72.65% 148.08%
Average Basic Shares Outstanding 0.86% 0.39%
Average Diluted Shares Outstanding -0.49% 4.55%
Dividend Per Share -- --
Payout Ratio -- --